Whatever their mode of binding, the analyzed SLURP-1 forms interact with the indicated nAChR subtypes and may find applications in developing drugs acting on these receptors involved in pain, inflammation and neurodegenerative diseases. This evidence concerns the gene CHRNA4 and neurodegenerative disease.